Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Powders is Scopus-indexed (Q2, CiteScore 3.7), WoS ESCI, DOAJ. Published by Multidisciplinary Digital Publishing Institute (MDPI).
Checked against the index lists dated .
ISSN 2674-0516Verify ISSN ↗
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 87 / 191 | 54th | Q2 |
| Chemical Engineering (miscellaneous) | 56 / 106 | 47th | Q3 |
| Ceramics and Composites | 71 / 133 | 46th | Q3 |
| Colloid and Surface Chemistry | 17 / 24 | 31st | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2022–present, best quartile Q2, CiteScore 3.7.
Powders is Q2 in Pharmaceutical Science (rank 87 of 191), Q3 in Chemical Engineering (miscellaneous) (rank 56 of 106) and Q3 in Ceramics and Composites (rank 71 of 133), by CiteScore 2025. It is ranked in 4 subject areas in all.
Powders is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.7, which places it in quartile Q2 at the 54th percentile of its subject.
The publisher lists an article processing charge of about US$1,207 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Powders is published by Multidisciplinary Digital Publishing Institute (MDPI). Its ISSN is 2674-0516.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Powders has an h-index of 13 and a 2-year mean of 3.66 citations per paper (OpenAlex). Its Scopus CiteScore is 3.7, quartile Q2. On 2-year citations it ranks #50 of 177 Scopus journals in Pharmaceutical Science.
Powders published 32 papers in 2025; its busiest recent year was 2023 with 47. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2023–2026), authors are most often from Germany (27.8%), United States (14.1%) and Brazil (14.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.